The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -23.36%.However, over the last six months, we can see a stronger performance of -43.84%. Over the last 30 days, the price of GPCR has leaped by -20.51%. And in the last five days, it has fallen by -7.44%.
Structure Therapeutics Inc ADR experienced a rather shaky stock market performance. The highest value in the past year was recorded at $64.45 on 12/06/23 and the lowest value was $26.61 on 12/18/23.
52-week price history of GPCR Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Structure Therapeutics Inc ADR’s current trading price is -51.53% away from its 52-week high, while its distance from the 52-week low is 17.40%. The stock’s price range during this period has varied between$26.61 and $64.45. The Structure Therapeutics Inc ADR’s shares, which operate in the Healthcare, saw a trading volume of around 1.02 million for the day, a figure considerably higher than their average daily volume of 0.76 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Structure Therapeutics Inc ADR (GPCR) has experienced a quarterly decline of -15.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.79B and boasts a workforce of 93 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 37.80, with a change in price of -13.42. Similarly, Structure Therapeutics Inc ADR recorded 750,870 in trading volume during the last 100 days, posting a change of -30.05%.
GPCR’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for GPCR stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
GPCR Stock Stochastic Average
Structure Therapeutics Inc ADR’s raw stochastic average for the past 50 days is presently 11.50%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 16.64%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 26.09% and 29.82%, respectively.
